Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
QDEL

QDEL - Quidel Corp Stock Price, Fair Value and News

37.33USD-2.64 (-6.60%)Market Closed

Market Summary

QDEL
USD37.33-2.64
Market Closed
-6.60%

QDEL Alerts

  • Big fall in Revenue (Y/Y)
  • Big fall in earnings (Y/Y)
  • Losses in recent quarter

QDEL Stock Price

View Fullscreen

QDEL RSI Chart

QDEL Valuation

Market Cap

2.5B

Price/Earnings (Trailing)

-1.42

Price/Sales (Trailing)

0.87

EV/EBITDA

-2.95

Price/Free Cashflow

-21.04

QDEL Price/Sales (Trailing)

QDEL Profitability

Operating Margin

97.86%

EBT Margin

-65.95%

Return on Equity

-53.36%

Return on Assets

-26.33%

Free Cashflow Yield

-4.75%

QDEL Fundamentals

QDEL Revenue

Revenue (TTM)

2.9B

Rev. Growth (Yr)

-15.97%

Rev. Growth (Qtr)

-4.26%

QDEL Earnings

Earnings (TTM)

-1.8B

Earnings Growth (Yr)

-3.6K%

Earnings Growth (Qtr)

-24.5K%

Breaking Down QDEL Revenue

Last 7 days

-12.3%

Last 30 days

-15.5%

Last 90 days

-22.9%

Trailing 12 Months

-55.9%

How does QDEL drawdown profile look like?

QDEL Financial Health

Current Ratio

1.55

Debt/Equity

0.68

Debt/Cashflow

0.04

QDEL Investor Care

Shares Dilution (1Y)

0.51%

Diluted EPS (TTM)

-26.38

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20242.9B000
20233.1B3.2B3.1B3.0B
20222.3B2.8B3.0B3.3B
202101.7B1.7B1.7B
20200001.7B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Quidel Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jun 06, 2024
rhoads ann d
acquired
-
-
1,220
-
Jun 01, 2024
busky joseph m
acquired
-
-
5,391
chief financial officer
Jun 01, 2024
iskra michael s.
sold (taxes)
-57,447
44.19
-1,300
evp & cco
Jun 01, 2024
iskra michael s.
acquired
-
-
3,594
evp & cco
Jun 01, 2024
busky joseph m
sold (taxes)
-108,089
44.19
-2,446
chief financial officer
May 28, 2024
prutow james
acquired
-
-
1,519
-
May 25, 2024
hodges michelle a.
sold (taxes)
-6,360
42.4
-150
svp, general counsel
May 25, 2024
hodges michelle a.
acquired
-
-
420
svp, general counsel
May 24, 2024
wilkins joseph d jr.
acquired
-
-
2,416
-
May 24, 2024
buechler kenneth f
acquired
-
-
2,416
-

1–10 of 50

Which funds bought or sold QDEL recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jun 11, 2024
EverSource Wealth Advisors, LLC
reduced
-15.57
-4,814
4,177
-%
Jun 06, 2024
WESTWOOD HOLDINGS GROUP INC
sold off
-100
-3,691,000
-
-%
Jun 04, 2024
Aurora Investment Counsel
sold off
-100
-708,152
-
-%
May 28, 2024
Boston Partners
sold off
-100
-10,605,300
-
-%
May 28, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
reduced
-16.4
-1,178,000
1,405,000
0.01%
May 21, 2024
LRI Investments, LLC
new
-
19,176
19,176
-%
May 20, 2024
EMC Capital Management
new
-
117,000
117,000
0.07%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-5.61
-1,522,180
2,420,920
-%
May 16, 2024
JANE STREET GROUP, LLC
reduced
-59.32
-3,020,330
1,086,750
-%
May 16, 2024
COMERICA BANK
reduced
-1.41
-1,882,080
3,364,620
0.01%

1–10 of 43

Are Funds Buying or Selling QDEL?

Are funds buying QDEL calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own QDEL
No. of Funds

Unveiling Quidel Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
May 14, 2024
carlyle group inc.
-
0
SC 13D/A
Feb 14, 2024
t. rowe price investment management, inc.
13.0%
8,698,143
SC 13G/A
Feb 13, 2024
vanguard group inc
7.25%
4,841,410
SC 13G/A
Jan 26, 2024
blackrock inc.
7.2%
4,797,921
SC 13G/A
May 05, 2022
senvest management, llc
5.17%
2,161,521
SC 13G
Feb 14, 2022
alger associates inc
5.3%
2,223,343
SC 13G
Feb 14, 2022
price t rowe associates inc /md/
14.6%
6,108,899
SC 13G/A
Feb 14, 2022
brown capital management llc
6.34%
2,642,671
SC 13G/A
Feb 10, 2022
vanguard group inc
8.22%
3,426,080
SC 13G/A
Feb 01, 2022
blackrock inc.
7.9%
3,301,994
SC 13G/A

Recent SEC filings of Quidel Corp

View All Filings
Date Filed Form Type Document
Jun 12, 2024
144
Notice of Insider Sale Intent
Jun 10, 2024
4
Insider Trading
Jun 04, 2024
4
Insider Trading
Jun 04, 2024
4
Insider Trading
May 30, 2024
4
Insider Trading
May 30, 2024
SD
SD
May 29, 2024
4
Insider Trading
May 29, 2024
4
Insider Trading
May 29, 2024
4
Insider Trading
May 29, 2024
4
Insider Trading

Quidel Corp News

Latest updates
Defense World21 hours ago
Yahoo Lifestyle Australia41 hours ago
The Motley Fool4 months ago

Quidel Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22020Q4
Revenue-4.3%7117437446658468677846131,002637510177-
Gross Profit---------740489373106701
Costs and Expenses---------11911392.0083.0084.00
  S&GA Expenses9.1%20518819417920221420411885.0074.0063.0054.00-
  R&D Expenses-0.2%59.0059.0062.0063.0062.0064.0066.0034.0026.0026.0024.0023.00-
EBITDA Margin-689.9%-0.55*0.09*0.11*0.12*0.14*0.29*0.40*0.51*0.58*0.56*0.64*0.65*0.65*
Interest Expenses-6.3%-39.00-36.70-37.70-36.50-36.70-34.70-29.70-10.30-1.00-1.10-1.30-1.40-
Income Taxes-473.5%-92.90-16.20-2.80-11.2011.0011.0012.0024.0014184.0066.003.00-
Earnings Before Taxes-19453.3%-1,798-9.20-15.50-64.4060.0041.0031.0043.0062137528222.00-
EBT Margin-6694.2%-0.66*-0.01*0.01*0.02*0.06*0.23*0.35*0.48*0.56*0.53*0.62*0.62*0.63*
Net Income-24471.4%-1,7067.00-12.70-53.2049.0030.0019.0019.0048029121619.00-
Net Income Margin-18199.7%-0.62*0.00*0.00*0.01*0.04*0.17*0.27*0.36*0.43*0.41*0.48*0.48*0.49*
Free Cashflow-310.1%-66.8032.00-1.90-81.90123108-40.20199478289-29.90--
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22021Q4
Assets-21.7%6,7038,5638,5398,5508,7878,8568,6568,8222,430
  Current Assets-7.5%1,2121,3111,3711,3081,4991,5751,4451,5591,440
    Cash Equivalents-34.0%79.00119149179355294213381803
  Inventory0.9%583578552542529524536553199
  Net PPE-0.2%1,4411,4441,3691,3761,3621,3391,2621,110349
  Goodwill-70.5%7352,4922,4432,4712,4912,4772,3582,590337
Liabilities-4.5%3,3963,5573,5723,5483,7913,9213,8603,903501
  Current Liabilities-6.5%7808348607909081,007873900324
  Long Term Debt-1.5%2,2412,2752,2752,3092,3802,4312,4822,5330.00
Shareholder's Equity-33.9%3,3085,0064,9675,0034,9974,9354,7954,9201,929
  Retained Earnings-78.0%4822,1882,1812,1942,2472,1982,1682,1481,649
  Additional Paid-In Capital0.1%2,8522,8482,8392,8252,8092,8042,7722,832280
Shares Outstanding0.1%67.0067.0067.0067.0067.0066.0054.0047.0042.00
Float----5,090---6,008-
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22020Q4
Cashflow From Operations-100.9%-0.7080.0042.00-30.60189169-9.7022550132177.00--
  Share Based Compensation-26.8%9.0012.0014.0014.0011.0012.0013.0016.007.007.007.00--
Cashflow From Investing63.3%-20.20-55.10-21.30-42.30-68.90-59.30-29.80-1,530-24.70-96.00-93.20--
Cashflow From Financing68.0%-18.50-57.80-48.70-99.70-59.60-31.70-126413-3.40-0.902.00--
  Buy Backs-100.0%-7.00----74.00----103-
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

QDEL Income Statement

2024-03-31
Consolidated Statements of (Loss) Income (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Income Statement [Abstract]  
Total revenues$ 711.0$ 846.1
Cost of sales, excluding amortization of intangibles378.9397.5
Selling, marketing and administrative204.7202.4
Research and development59.262.3
Amortization of intangible assets51.750.8
Acquisition and integration costs22.629.7
Goodwill impairment charge1,743.90.0
Other operating expenses8.03.8
Operating (loss) income(1,758.0)99.6
Interest expense, net39.036.7
Other expense, net1.92.9
(Loss) income before income taxes(1,798.9)60.0
(Benefit from) provision for income taxes(92.9)11.2
Net (loss) income$ (1,706.0)$ 48.8
Basic (loss) earnings per share$ (25.50)$ 0.73
Diluted (loss) earnings per share$ (25.50)$ 0.73
Weighted-average shares outstanding - basic66.966.6
Weighted-average shares outstanding - diluted66.967.1

QDEL Balance Sheet

2024-03-31
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 78.5$ 118.9
Marketable securities0.048.4
Accounts receivable, net271.7303.3
Inventories583.1577.8
Prepaid expenses and other current assets279.1262.1
Total current assets1,212.41,310.5
Property, plant and equipment, net1,441.31,443.8
Marketable securities0.07.4
Right-of-use assets180.5169.6
Goodwill734.82,492.0
Intangible assets, net2,887.32,934.3
Deferred tax asset24.925.9
Other assets222.1179.6
Total assets6,703.38,563.1
Current liabilities:  
Accounts payable249.6294.8
Accrued payroll and related expenses108.984.8
Income tax payable9.511.1
Current portion of borrowings161.1139.8
Other current liabilities250.7303.3
Total current liabilities779.8833.8
Operating lease liabilities181.8172.8
Long-term borrowings2,241.02,274.8
Deferred tax liability125.6192.2
Other liabilities67.483.6
Total liabilities3,395.63,557.2
Commitments and contingencies (Note 10)
Stockholders’ equity:  
Preferred stock, $0.001 par value per share; 5.0 shares authorized; none issued or outstanding at March 31, 2024 and December 31, 20230.00.0
Common stock, $0.001 par value per share; 126.2 shares authorized; 66.8 and 66.7 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively0.10.1
Additional paid-in capital2,852.02,848.0
Accumulated other comprehensive loss(26.2)(30.0)
Retained earnings481.82,187.8
Total stockholders’ equity3,307.75,005.9
Total liabilities and stockholders’ equity$ 6,703.3$ 8,563.1
QDEL
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.
 CEO
 WEBSITEquidelortho.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES7000

Quidel Corp Frequently Asked Questions


What is the ticker symbol for Quidel Corp? What does QDEL stand for in stocks?

QDEL is the stock ticker symbol of Quidel Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Quidel Corp (QDEL)?

As of Thu Jun 13 2024, market cap of Quidel Corp is 2.5 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of QDEL stock?

You can check QDEL's fair value in chart for subscribers.

What is the fair value of QDEL stock?

You can check QDEL's fair value in chart for subscribers. The fair value of Quidel Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Quidel Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for QDEL so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Quidel Corp a good stock to buy?

The fair value guage provides a quick view whether QDEL is over valued or under valued. Whether Quidel Corp is cheap or expensive depends on the assumptions which impact Quidel Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for QDEL.

What is Quidel Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Jun 13 2024, QDEL's PE ratio (Price to Earnings) is -1.42 and Price to Sales (PS) ratio is 0.87. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. QDEL PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Quidel Corp's stock?

In the past 10 years, Quidel Corp has provided 0.052 (multiply by 100 for percentage) rate of return.